Joshua H. Bilenker - Net Worth and Insider Trading
Joshua H. Bilenker Net Worth
The estimated net worth of Joshua H. Bilenker is at least $46 Million dollars as of 2024-11-29. Joshua H. Bilenker is the President & CEO of Loxo Oncology Inc and owns about 194,407 shares of Loxo Oncology Inc (LOXO) stock worth over $46 Million. Joshua H. Bilenker is also the Director of Sana Biotechnology Inc and owns about 20,000 shares of Sana Biotechnology Inc (SANA) stock worth over $51,000. Details can be seen in Joshua H. Bilenker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua H. Bilenker has not made any transactions after 2021-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joshua H. Bilenker
Joshua H. Bilenker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua H. Bilenker owns 6 companies in total, including Gossamer Bio Inc (GOSS) , Loxo Oncology Inc (LOXO) , and ViewRay Inc (VRAYQ) among others .
Click here to see the complete history of Joshua H. Bilenker’s form 4 insider trades.
Insider Ownership Summary of Joshua H. Bilenker
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GOSS | Gossamer Bio Inc | 2019-02-07 | director |
LOXO | Loxo Oncology Inc | 2019-02-15 | director & President & CEO |
VRAYQ | ViewRay Inc | 2016-03-30 | director & 10 percent owner |
2014-08-06 | director | ||
2014-07-16 | director | ||
2021-02-03 | director |
Joshua H. Bilenker Latest Holdings Summary
Joshua H. Bilenker currently owns a total of 2 stocks. Among these stocks, Joshua H. Bilenker owns 194,407 shares of Loxo Oncology Inc (LOXO) as of December 11, 2018, with a value of $46 Million and a weighting of 99.89%. Joshua H. Bilenker also owns 20,000 shares of Sana Biotechnology Inc (SANA) as of February 3, 2021, with a value of $51,000 and a weighting of 0.11%.
Latest Holdings of Joshua H. Bilenker
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LOXO | Loxo Oncology Inc | 2018-12-11 | 194,407 | 234.66 | 45,619,547 |
SANA | Sana Biotechnology Inc | 2021-02-03 | 20,000 | 2.55 | 51,000 |
Holding Weightings of Joshua H. Bilenker
Joshua H. Bilenker Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua H. Bilenker has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 20,000 shares on December 11, 2018, which brought Joshua H. Bilenker around $3 Million.
According to the SEC Form 4 filings, Joshua H. Bilenker has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sana Biotechnology Inc is the acquisition of 20,000 shares on February 3, 2021, which cost Joshua H. Bilenker around $500,000.
Insider Trading History of Joshua H. Bilenker
- 1
Joshua H. Bilenker Trading Performance
Joshua H. Bilenker Ownership Network
Joshua H. Bilenker Owned Company Details
What does Gossamer Bio Inc do?
Who are the key executives at Gossamer Bio Inc?
Joshua H. Bilenker is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and Chief Financial Officer Bryan Giraudo .
Gossamer Bio Inc (GOSS) Insider Trades Summary
Over the past 18 months, Joshua H. Bilenker made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net sale of 7,740 shares made by Richard Aranda , and a net purchase of 348,828 shares made by Faheem Hasnain .
In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,790 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 681,210 shares.
Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gossamer Bio Inc Insider Transactions
Joshua H. Bilenker Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua H. Bilenker. You might contact Joshua H. Bilenker via mailing address: C/o Loxo Oncology, Inc., One Landmark Square, Suite 1122, Stamford Ct 06901.